Company Monitoring Page for Roche

latest headlines for company on cafepharma

FDA adds two Roche studies to its growing list of partial clinical holds in wake of Keytruda deaths
Endpoints
Sat, 09/16/17 - 12:06 pm
Tags:
FDA, Roche, Keytruda, Tecentriq, clinical trials
Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?
Motley Fool
Sat, 09/16/17 - 12:05 pm
Tags:
Halozyme, Inovalon, Teva Pharmaceutical, Unitedhealthcare Group, Roche, Bristol-Myers Squibb
FDA commish cheers on biosimilars as Amgen, Allergan score OK for knockoff of Roche’s Avastin
Endpoints
Fri, 09/15/17 - 09:14 am
Tags:
FDA, Scott Gottlieb, Amgen, Allergan, biosimilars, Mvasi, Roche, Avastin
FDA says Tecentriq won't lose its bladder cancer nod despite phase 3 failure, Roche reports
Fierce Pharma
Tue, 09/12/17 - 10:00 pm
Tags:
FDA, Tecentriq, Roche, bladder cancer, clinical trials
Roche gets hit with another big R&D setback as a prospective AMD blockbuster flops in PhIII
Endpoints
Sat, 09/9/17 - 02:14 pm
Tags:
Roche, R&D, AMD, lampalizumab
An accurate analysis of the differences between Swiss companies Roche and Novartis
GoInPharma
Sat, 09/9/17 - 01:22 pm
Tags:
Novartis, Roche, Switzerland
Parkinson's Now a Hot Therapeutic Area: What's Up Lately?
Yahoo/Zacks.com
Sat, 09/2/17 - 11:11 am
Tags:
Parkinson's Disease, Novartis, Teva Pharmaceutial, UCB Pharma, MEDI1341, AstraZeneca, Takeda, PRX002, Prothena, Roche, Acorda, Inbrija, Adamas Pharmaceuticals, Gocovri
Best Pharma Stocks Based on R&D Spending
Motley Fool
Mon, 08/28/17 - 09:27 am
Tags:
R&D, pharma stocks, Roche, Novartis, Pfizer, JNJ, Merck
Under fire from Shire, Roche grabs the VIP lane for top drug prospect emicizumab
Endpoints
Thu, 08/24/17 - 09:53 am
Tags:
Shire, Roche, emicizumab, hemophilia A
Personal turf is ‘out,’ community workplaces are ‘in’ at the new Roche neighborhood
Endpoints
Mon, 08/21/17 - 11:24 am
Tags:
Roche, employees
An analysis of 2017 first half for pharmaceutical industry
GoInPharma
Sat, 08/19/17 - 10:51 am
Tags:
pharma industry, Pfizer, Sanofi, GSK, Roche, Celgene, Bristol-Myers Squibb
Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers
Fierce Pharma
Thu, 08/17/17 - 11:48 pm
Tags:
multiple sclerosis, MS, drug pricing, Bayer, Biogen, Merck KGaA, Novartis, Sanofi, Teva Pharmaceutical, Roche
Roche, Mimetas develop “gut-on-a-chip” tech for drug-testing
Drug Delivery Business News
Thu, 08/17/17 - 10:04 am
Tags:
Roche, Mimetas, drug development
New target could yield treatment for Alzheimer's, ALS and more
Fierce Biotech
Thu, 08/17/17 - 09:57 am
Tags:
Genentech, Roche, drug development, R&D, Alzheimer's disease, ALS
Drug developers face increasingly risky tightrope walk between top-line results and hard data
Endpoints
Tue, 08/15/17 - 10:57 am
Tags:
drug development, clinical trials, late stage data, Roche, Perjeta
Pharma's giants, new and old, tell more tales than their numbers show
Fierce Pharma
Fri, 08/11/17 - 11:16 am
Tags:
Big Pharma, JNJ, Pfizer, GSK, Roche, Novartis, Sanofi, Bristol-Myers Squibb
The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results
Fierce Pharma
Thu, 08/10/17 - 06:58 pm
Tags:
pharma stocks, Merck, Pfizer, AbbVie, Eli Lilly, Bristol-Myers Squibb, GSK, Roche, Sanofi, Bayer, Novo Nordisk, Celgene, Biogen, AstraZeneca
Dermira Commits $135M for Global Rights to Roche Eczema Drug
Xconomy
Tue, 08/8/17 - 11:15 pm
Tags:
Demira, Roche, eczema, lebrikizumab
As Roche wades biosimilar waters, more competitors circle Herceptin
BioPharma Dive
Wed, 08/2/17 - 09:28 pm
Tags:
Roche, Herceptin, biosimilars, Amgen, Allergan, ABP 980, Celltrion, CT-P6
FDA advances two more Herceptin biosims—this time from Amgen and Teva—as Roche braces for impact
Fierce Pharma
Mon, 07/31/17 - 09:56 pm
Tags:
FDA, Herceptin, biosimilars, Roche, Amgen, Teva Pharmaceutical, Allergan, Celltrion

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.